SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 24.79 |
| Enterprise Value ($M) | 17.28 |
| Book Value ($M) | 38.64 |
| Book Value / Share | 1.39 |
| Price / Book | 0.64 |
| NCAV ($M) | 34.52 |
| NCAV / Share | 1.24 |
| Price / NCAV | 0.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.68 |
| Return on Assets (ROA) | -0.56 |
| Return on Equity (ROE) | -0.62 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.10 |
| Current Ratio | 9.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 41.17 |
| Assets | 45.29 |
| Liabilities | 6.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.55 |
| Operating Income | -29.30 |
| Net Income | -27.24 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -17.73 |
| Cash from Investing | -9.74 |
| Cash from Financing | 21.81 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Arkin Moshe | 60.80 | ||
| 13G | Armistice Capital, Llc | 7.68 | ||
| 13G/A | Phoenix Holdings Ltd. | 9.26 | 0.00 | |
| 13G | Migdal Insurance & Financial Holdings Ltd. | 5.31 | -0.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 58 | 945 | 6.14 | |
| 843 | 43,014 | 1.96 | |
| 123 | 2,899 | 4.24 | |
| 3 | 2,201 | 0.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SGMT – Sagimet Biosciences Inc. | SIGA – SIGA Technologies, Inc. |
| SKYE – Skye Bioscience, Inc. | SMMT – Summit Therapeutics Inc. |
| SNSE – Sensei Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io